Schreiner MediPharm's "Cap-Lock" label integrates RFID technology for enhanced syringe protection and digital tracking, replacing traditional blister packs with a sustainable alternative. The RFID ...

At the Cell and Gene Meeting on the Mesa, a panel discussion was held on advanced therapy production and how it demands ...

The awarded $1.7 million in funding will support the company’s preclinical and clinical progress on DMX-1001 (noribogaine), ...

The licensing of Talicia, an FDA-approved fixed-dose therapy, to key at-risk markets strategically combats an increasingly ...

The growing demand for liquid medicines is increasingly driven by the unique needs of several distinct patient groups, improving compliance in these demographics through flexible, palatable dosing ...

Siegfried Schmitt, PhD, vice-president, Technical at Parexel, answers questions on the use and benefits of real-world evidence for small-molecule and large-molecule drug development.

In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

The 100% tariff on imported drugs will pressure pharma companies to build manufacturing sites in the US or face significant ...

Pharmaceutical Technology® spoke with Juliana Maynard, PhD, Head of Translational Imaging, at Medicines Discovery Catapult, ...

Pharmaceutical Technology® spoke with Bryan Miller, Director of Scientific and Technical Operations at Crown Bioscience UK, to learn more about Crown Bioscience’s collaboration with Medicines ...

Pfizer re-balances weight loss portfolio with Metsera, Bristol Myers Squibb and Roche make Breast cancer progress, and ...

In this episode of the Ask the Expert video series, Susan J. Schniepp, Regulatory Compliance Associates, and Siegfried Schmitt, PhD, Parexel, answer questions on the use of real-world evidence for ...